Supplemental material
Emerging Microbes & Infections
Volume 8, 2019 - Issue 1
Original Articles
Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection
, , , , , , , 
, , , , , , & show all
Jiuyang Xua Comprehensive AIDS Research Center, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, People’s Republic of Chinahttps://orcid.org/0000-0002-1906-5918View further author information
https://orcid.org/0000-0002-1906-5918View further author information, , , , , , Stanley Perlmanb Department of Microbiology and Immunology, The University of Iowa, Iowa City, IA, USA;g State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-4213-2354View further author information
https://orcid.org/0000-0003-4213-2354View further author information & Linqi Zhanga Comprehensive AIDS Research Center, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-4931-509XView further author information
https://orcid.org/0000-0003-4931-509XView further author information show allRelated Research Data
MERS-CoV vaccine candidates in development: The current landscape
Source:
Elsevier BV
Middle East respiratory syndrome vaccines
Source:
Elsevier BV
Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice.
Source:
Proceedings of the National Academy of Sciences
A novel nanobody targeting middle east respiratory syndrome coronavirus (MERS-CoV) receptor-binding domain has potent cross-neutralizing activity and protective efficacy against MERS-CoV
Source:
American Society for Microbiology
Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1
Source:
Elsevier BV
Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections.
Source:
Elsevier BV
Mucosal immunity and vaccines
Source:
Springer Science and Business Media LLC
The molecular biology of coronaviruses.
Source:
Elsevier
MERS coronavirus infection in humans and animals
Source:
Wiley
Identification of MERS-CoV in Dromedary Camels
Source:
Elsevier BV
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
Source:
American Society for Microbiology
Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice.
Source:
MDPI AG
Rapid generation of a mouse model for Middle East respiratory syndrome
Source:
Proceedings of the National Academy of Sciences
A decade after SARS: strategies for controlling emerging coronaviruses
Source:
Macmillan Publishers
Antibodies and vaccines against Middle East respiratory syndrome coronavirus
Source:
Informa UK Limited
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4.
Source:
Springer Science and Business Media LLC
Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.
Source:
American Association for the Advancement of Science (AAAS)
Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection
Source:
Figshare
Asymptomatic SARS coronavirus infection among healthcare workers, Singapore
Source:
Centers for Disease Control and Prevention (CDC)
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
Source:
Elsevier
Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003
Source:
Elsevier BV
Potent human neutralizing antibodies elicited by SARS-CoV-2 infection
Source:
Cold Spring Harbor Laboratory
Chimpanzee Adenovirus Vector Ebola Vaccine
Source:
Massachusetts Medical Society
The receptor binding domain of MERS-CoV: the dawn of vaccine and treatment development.
Source:
Published by Elsevier (Singapore) Pte Ltd.
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Source:
Springer Science and Business Media LLC
A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
Source:
American Association for the Advancement of Science (AAAS)
One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus
Source:
American Society for Microbiology
Linking provided by
